The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Decapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection



Ipsen Pharmaceuticals LimitedPA0869/003/003

Main Information

Trade NameDecapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection
Active SubstancesTriptorelin pamoate
Dosage FormPowder and solvent for prolonged-release suspension for injection
Licence HolderIpsen Pharmaceuticals Limited
Licence NumberPA0869/003/003

Group Information

ATC CodeL02AE Gonadotropin releasing hormone analogues
L02AE04 triptorelin

Status

License statusAuthorised
Licence Issued08/04/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back